The SAIC and Georgetown glucose sensor technology has been developed for DARPA and can be combined with Gentag's cell phone RFID-sensor reader platform technology.
Under the terms of the agreement, Gentag, Georgetown and SAIC have agreed to pool their IP and to sell or license the combined technology to a company developing glucose monitors or insulin-delivery systems under a competitive bidding process.
The technology is protected by twenty-one issued and pending U.S. and international patents. Diabetes is a growing international health problem. In the United States, medical expenditures totaled $116 billion in 2007 and were comprised of $27 billion for diabetes care, $58 billion for chronic diabetes-related complications, and $31 billion for excess general medical costs according to the American Diabetes Association.
For more information about acquisition or licensing terms, please contact Claudia Stewart, Vice President, Office of Technology Commercialization, Georgetown University at (202)-687-7424 or at cs477@georgetown.edu.
About Gentag
Gentag, Inc. is a technology development company focusing on the
creation of innovative, low-cost, wireless sensor technologies based on
cell phones. The company owns a unique intellectual property portfolio
relating to cell-phone sensor combinations and wireless sensor networks and
was recently awarded Frost & Sullivan's 2008 North American Award for
Technology Innovation. For more information, visit http://www.gentag.com.
'/>"/>
| SOURCE Georgetown University; Gentag, Inc. Copyright©2008 PR Newswire. All rights reserved |